Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond
GeekWire
FEBRUARY 8, 2022
billion in venture capital 2021, more than twice the amount in 2019, according to real estate firm CBRE. of Juno at its IPO, and the institution’s research budget fattened with the company’s success. The technology is licensed and sometimes disappears into a black box. “We We’re hiring and we’re growing.”.
98 
Let's personalize your content